INTRODUCTION
============

Friedreich\'s ataxia (FRDA) is the most commonly inherited ataxia, occurring in 1--2 of every 50 000 people ([@B1],[@B2]). It is characterized by muscle weakness along with progressive gait and limb ataxia and is often accompanied by vision impairment, skeletal abnormalities, heart disease and diabetes ([@B3]). FRDA is a recessive disease that is predominantly caused by expansions of (GAA)*~n~* repeats within the first intron of the human frataxin gene *X25* ([@B4]). These expansions lead to the lowered level of the frataxin protein, which is responsible for iron metabolism in mitochondria, resulting in disease ([@B5]). Short (GAA)*~n~* repeats, ranging from 5 to 34 units, are always present in normal frataxin alleles and were apparently originated by the primordial insertion of an Alu element ([@B6]). In FRDA alleles, (GAA)*~n~* stretches range from 66 to 1700 units ([@B7]). It is believed that these expanded stretches affect transcription of the *X25* gene since FRDA patients have low levels of the frataxin mRNA ([@B8],[@B9]). Further support for transcription inhibition by expanded (GAA)*~n~* stretches was obtained in transient transfection experiments with cultured mammalian cells ([@B10]).

The exact mechanisms responsible for transcription inhibition by long (GAA)*~n~* repeats are not entirely clear. Several groups have demonstrated that transcription elongation *in vitro* was disrupted by (GAA)*~n~* runs ([@B9],[@B11],[@B12]). On linear templates, (GAA)*~n~* repeats efficiently trapped T7 RNA polymerase leading to the reduced amounts of the full-length transcripts, but premature termination was not detected ([@B11]). In contrast, on supercoiled templates, transcripts prematurely terminated at the 3′ ends of repeats ([@B11]). Transcription inhibition *in vitro* was linked to the repeat\'s ability to form triple-helical H-DNA or a composite triplex structure, called sticky DNA ([@B11],[@B12]). Intramolecular triplexes formed by (GAA)*~n~*·(TTC)*~n~* can exist in either H-y or H-r conformations depending on the nature of the third DNA strand ([@B13],[@B14]). The H-r conformation is more likely to form during transcription *in vitro*, as it is stabilized by the presence of magnesium cations presented in transcription mixtures. The H-r triplex is more favorable in superhelical DNA than in linear DNA and could be additionally stabilized by the homopurine RNA tail, formed after RNA polymerase has passed the repeat ([@B15]).

The interpretation of the data on transcriptional repression *in vivo* is somewhat less obvious. Formation of triplex-like structures was suggested to cause transcription inhibition at expanded repeats in transient transfection experiments ([@B10]). An alternative explanation could be a manifold binding of nuclear protein(s) to the expanded repeat. (GAA)*~n~*-binding proteins were indeed identified in HeLa nuclear extracts ([@B16]). Another possibility could be an alteration in RNA splicing, processing or stability caused by the expanded repeat. Finally, expansions of (GAA)*~n~* repeats could lead to the formation of heterochromatin, thus silencing the frataxin gene. Supporting this, long (GAA)*~n~* stretches led to the expression variegation of an adjacent reporter in mice ([@B17]). The reversal of the frataxin gene silencing in FRDA lymphocytes by the synthetic histone deacetylase inhibitors further supports the role of heterochromatin formation in the disease ([@B18]).

In this study, we looked at the effects of (GAA)*~n~*·(TTC)*~n~* repeats on RNA synthesis by *E. coli* RNA polymerase *in vitro* and *in vivo*. This system, where formation of heterochromatin or RNA splicing are out of the question, allowed us to concentrate on the effects of FRDA repeats on transcription and RNA stability. We have found that expanded (GAA)*~n~* repeats, when in the sense strand for transcription, impair RNA polymerase progression. While elongating RNA polymerase is severely slowed by the repeat, it does not dissociate from the template. Surprisingly, in an opposite orientation of the repeat, i.e. when the (TTC)*~n~* run is in the sense strand for transcription, truncated RNA species accumulate even for normal-size repeats. We found that cleavage of full-length mRNAs within (UUC)*~n~* runs by the *E. coli* degradosome is responsible for these truncations.

MATERIALS AND METHODS
=====================

Bacteria
--------

*E. coli* JM109 strain (Promega) was used for maintaining the p185ΔCTT10 and p185ΔCTT20 plasmids. Strains carrying these plasmids were grown at 37°C in LB media containing 10 μg/ml tetracycline. Longer (TTC)*~n~* repeats were maintained in a JM109 derivative carrying an extra pTrc99A plasmid to prevent leakage of the *trc*-promoter in repeat-containing plasmids. Expanded GAA repeats were maintained in an N3433 (*lacZ43*(*Fs*), *relA1, spoT1, thi-1*)-derived strain also carrying an extra pTrc99A plasmid. Plasmid-bearing strains were grown at 37°C in minimal M9 media supplemented with 1 μg/ml vitamin B1, 40 μg/ml amino acids mix, 10 μg/ml tetracycline and 50 μg/ml ampicillin. For RNA isolation, they were grown until *A*~600~ ∼ 0.2, then IPTG (Sigma) was added to 2 mM and cells were incubated for another 1 h.

Strain N3431 (*lacZ43*(*Fs*), *λ*−, *rne-3071(ts*), *relA1, spoT1, thi-1*), carrying the temperature-sensitive mutation in the RNase E gene, was obtained courtesy of the *E. coli* Genetic Stock Center. For RNA isolation, this strain was grown at 30°C up to *A*~600~ ∼ 0.4, then transferred to 43°C for 1 h. Transcription was induced by the addition of 2 mM IPTG for 40 min prior to cell harvesting. For the experiments with protein synthesis inhibition, N3431 cells were grown at 30°C until the early logarithmic stage (*A*~600~ = 0.2), followed by the addition of chloramphenicol (170 μg/ml) and subsequent incubation for 2 h. Cultures were then transferred to 43°C for 1 h. Transcription was induced by the addition of 2 mM IPTG for 40 min prior to cell harvesting.

Yeast
-----

Yeast transcription experiments were performed in *Saccharomyces cerevisiae* CH1585 (*MATa leu2Δ1 trpΔ63 ura3-52 his3-200*) strain (ATCC 96098) transformed with pYES2-derived plasmids carrying (GAA)*~n~*·(TTC)*~n~* repeats, as described earlier ([@B19]).

Plasmids for transcription studies *in vivo*
--------------------------------------------

The p185Δ vector for cloning of various (GAA)*~n~*·(TTC)*~n~* repeats was obtained in two steps. First, the p185 plasmid was made by ligating the PstI--BspHI fragment, carrying the *cat* gene from the pTrcCAT/Pst plasmid ([@B20]), with the XmnI--BsaAI fragment of the pACYC184 plasmid (New England Biolabs), carrying the p15A replication origin and *tet* gene. To improve stability of the *cat* mRNA, a BsrDI--XmnI fragment from the *cat* gene was deleted from the resultant plasmid.

To obtain the p185ΔGAA57 and p185ΔCTT57 plasmids, an EcoRI--HindIII fragment of the pBluescript-GAA57 ([@B19]), carrying the (GAA)~57~·(TTC)~57~ repeat, was cloned into the Kpn2I site of the p185Δ in both orientations. To obtain the p185ΔGAA114 plasmid, a (GAA)~114~·(TTC)~114~ repeat was excised upon the BsgI digestion from the pYES--GAA114 ([@B19]) and re-cloned into the Kpn2I site of the p185Δ. Other repeat lengths were generated as a result of spontaneous deletions of the (GAA)~114~·(TTC)~114~ repeat during the cultivation of the p185ΔGAA114 plasmid.

Plasmids with the (TTC)~15~ repeat and its mutative derivatives were obtained by cloning pre-annealed pairs of oligonucleotides into the Kpn2I site of the p185Δ. 5′-CCGG(TTC)~15~TGT-3′ and 5′-CCGGAC(AAG)~15~A-3′ were used to generate the p185CTT15 plasmid; 5′-CCGG(TTC)~8~TCT(TTC)~2~TCTTT(CTT)~2~GT-3′ and 5′-CCGGAC(AAG)~2~AAAGA(GAA)~2~AGA(GAA)~8~-3′ were used to create the p185CTT15-M1 plasmid; 5′-CCGG(TTC)~2~TTTCT(CTT)~2~TCT(CTT)~8~GT-3′ and 5′-CCGGAC(AAG)~8~AGA(AAG)~2~AGAAA(GAA)~2~-3′ were used for obtaining the p185CTT15-M2 plasmid; and 5′-CCGG(TTC)~2~TTTCT(CTT)~2~TCTCTTCTCT(TTC)~2~TCTTT(CTT)~2~GT-3′ and 5′-CCGGAC(AAG)~2~AAAGA(GAA)~2~AGAGAAGAGA(AAG)~2~AGAAA(GAA)~2~-3′ were used for generating the p185CTT15-M12 plasmid.

Yeast plasmids pYES--Control and pYES--TTC57 for yeast transcription studies were described earlier ([@B19]). Plasmids pYES--TTC35 and pYES--TTC20 were obtained by cloning the EcoRI--Kpn2I repeat-containing fragments from the p185ΔTTC20 and p185ΔTTC35 plasmids, respectively, into the XhoI site of the pYES+ plasmid ([@B19]).

Plasmids for transcription studies *in vitro*
---------------------------------------------

The plasmid pYES--GAA57TspR1 was obtained as follows. A 6608-bp fragment was generated upon partial digestion of the pYES--GAA57 plasmid ([@B19]) with BsgI. This fragment was then digested with KpnI and ligated to the pre-annealed oligonucleotides 5′-CGGCACTGGGCGGCCGCTCGAAGCTTGATGA-3′ and 5′-ATCAAGCTTCGAGCGGCCGCCCAGTGCCGGTAC-3′.

The plasmid pYES--TTC57TspR1 was obtained by ligating pre-annealed oligonucleotides 5′-CATCGATGGCACTGGGC-3′ and 5′-GGCCGCCCAGTGCATCGATGGTAC-3′ to the pYES--TTC57 plasmid ([@B19]) digested with the NotI and KpnI endonucleases.

The plasmid YEp24TspR1 was obtained by ligating pre-annealed oligonucleotides 5′-CCGGCACTGGGCGGCCGCTCGAAGCTTGATGCATG-3′ and 5′-CATCAAGCTTCGAGCGGCCGCCCAGTG-3′ to the YEp24 vector (New England Biolabs) digested with SphI and Kpn21 endonucleases.

For transcription studies *in vitro*, preformed initiation complexes were ligated to one of the following fragments: (i) a 208-bp TspR1--AlwN1 fragment of the pYES--GAA57TspR1 plasmid; (ii) a 214-bp TspR1--EcoRI fragment of the pYES--TTC57TspR1 plasmid; or (iii) a 220-bp TspR1--BamH1 fragment of the Yep24TspR1 plasmid.

Analysis of RNA synthesis and stability *in vivo*
-------------------------------------------------

RNA from *E. coli* cells was isolated by a modified method of Dennis and Nomura as described earlier ([@B21]). Northern blot hybridization was performed according to standard protocol ([@B22]). RNA samples were denatured in 2.2 M formaldehyde, 1 × MOPS, 50% v/v deionized formamide followed by the separation in a 1.5% agarose gel containing 2.2 M formaldehyde in a 1 × MOPS buffer. The gel was capillary-blotted onto a Hybond N+ membrane (Amersham). Membranes were hybridized either with the 279-bp EcoRI--KpnI fragment of the p185, corresponding to 5′ part of the reporter\'s mRNA, or with an oligonucleotide 5′-AAAACATTGCATACGGAATTCCGG-3′ that corresponds to the sequence immediately downstream from the (TTC)*~n~* stretch. All fragments were radioactively labeled using the Hexalabel DNA labeling kit (Fermentas). Oligonucleotides for hybridization were labeled with T4 polynucleotide kinase (Invitrogen).

To analyze RNA stability *in vivo, E. coli* cultures were grown up to OD = 0.3, 2 mM IPTG was added, and cell growth was continued for 20 min. After addition of rifampicin (0.2 mg/ml) to block transcription, cell culture aliquots were taken at 0, 7, 12 and 17 min. These aliquots were instantly mixed with ice-cold phenol--ethanol, pelleted and frozen at −70°C. RNA was isolated, and equal amounts of total mRNA were analyzed by northern blot hybridization as described above.

Yeast RNA was isolated from 10 ml of cultures exponentially growing in the complete URA-synthetic medium with galactose using the RNeasy Mini Kit (Qiagen). Northern blot hybridization was performed according to the standard protocol ([@B22]). RNA samples were denatured in 2.2 M formaldehyde, 1 × MOPS, 50% (v/v) deionized formamide and separated in the 1.5% agarose gel with 2.2 M formaldehyde in the 1 × MOPS buffer. The gel was capillary-blotted onto a Hybond N+ membrane (Amersham). The membrane was hybridized with either the 112-bp PvuII--XhoI fragment or the 473-bp BamHI--EcoRI fragment of the pYES+, corresponding to the 5′- or 3′-part, respectively, of the analyzed mRNA.

Transcription *in vitro*
------------------------

Promoter-independent assembly of elongation complexes and their ligation to the repeat-containing and control fragments was done as described earlier ([@B23]). Elongation complexes were immobilized on Ni-NTA agarose via a hexahistidine tag on the largest subunit of RNA polymerase. Prior to the assembly, the RNA was labeled at its 5′ end by the T4 polynucleotide kinase in the presence of 500 μCi of γ-^32^P ATP (MP Biomedicals, Irvine, CA). For transcription analyses, the assembled complexes were moved beyond the ligation junction by incubation with 100 μM each of ATP, GTP and CTP to form an elongation complex with 45-nt RNA (EC45). EC45 was chased with 1 mM of all four NTPs (Roche Biosciences, Palo Alto, CA).

RESULTS
=======

Effects of expanded (GAA)*~n~* repeats on transcription *in vivo*
-----------------------------------------------------------------

To study transcription through (GAA)*~n~* repeats of increasing lengths, they were cloned into a pACYC184-derived plasmid p185Δ downstream from an artificial *trc* promoter inside the *cat* gene ([Figure 1](#F1){ref-type="fig"}A). This promoter is a hybrid between the 5′ part of the *trp* promoter and the 3′ part of the *lacUV5* promoter, i.e. it is inducible by IPTG but is not a subject for catabolic repression ([@B24]). A strong terminator from the *E. coli rrn*B gene contributes to the stability of the *cat* mRNA. For the purpose of this study, we have deleted a 3′ portion of the *cat* gene, making the transcript approximately 500 nt shorter. To clone the longest repeats, it was crucial to achieve complete repression of the *trc* promoter, as the stability of the repeats appeared to decrease in transcribed areas ([@B25]). For this purpose, repeat-containing plasmids were co-transformed with the compatible pTrc99A plasmid ([@B24]) carrying *lacI^q^* repressor gene. Figure 1.Effect of expanded (GAA)*~n~* repeats on RNA synthesis in *E. coli*. **(A)** Structure of the p185Δ plasmid, carrying (GAA)*~n~*·(TTC)*~n~* repeats in different orientations. **(B)** Northern blot analysis of GAA-containing mRNAs from the wild-type *E. coli* cells. Total RNA was hybridized with a probe, corresponding to either the 5′ part of the *cat* gene (upper panel) or RNAI, corresponding to the p15A origin (lower panel). **(C)** Quantitative analysis of the above data. **(D)** Normalized amounts of GAA-containing mRNAs from cells treated with chloramphenicol. **(E)** Normalized amount of the GAA-containing mRNAs from the *rne*(*ts*) mutant strain upon its cultivation at the non-permissive temperature.

Total RNA from cells containing plasmids with different (GAA)*~n~* repeats in the sense strand for transcription were separated in the denaturing agarose gel, followed by the detection of repeat-containing transcripts via northern hybridization with the probe to the 5′ part of the *cat* gene ([Figure 1](#F1){ref-type="fig"}A). Since long (GAA)*~n~* repeats are known to affect plasmid replication ([@B26]), normalizing repeat-containing transcripts to the plasmid copy number was necessary. For this purpose, the same gel was hybridized with the probe specific to the repressor RNAI for the pACYC184 replication origin, the amount of which directly reflects the plasmid copy number. Our primary results are presented in [Figure 1](#F1){ref-type="fig"}B and their quantitative analysis is shown in [Figure 1](#F1){ref-type="fig"}C. Rather unexpectedly, lengthening of (GAA)*~n~* repeats first leads to an increase in the amount of the full-sized transcript, reaching 3-fold at 30 repeats, followed by its gradual decrease down to the control level at 100 repeats.

On the one hand, these results are consistent with the earlier observations ([@B8],[@B9]) that an increase in the repeat\'s length from 30 to 100 units results in a 3-fold decrease in the amount of transcript. On the other hand, this inhibitory effect is masked in our experiment by the fact that short repeats amplify the amount of transcript relative to the control, repeat-free RNA. The latter could be due to either RNA stabilization or transcription stimulation somehow mediated by short repeats. Both processes are likely to depend on protein binding to the repeat in either RNA or DNA form. We thus decided to evaluate transcription of repeat-containing plasmids in cells that were extensively incubated with the protein synthesis inhibitor chloramphenicol.

Protein synthesis *de novo* is not required for the replication of our plasmids. Consequently, they rapidly amplify in the presence of chloramphenicol while the cellular protein content remains stagnant. Thus, if a protein binding to (GAA)*~n~* repeats is responsible for their stimulatory effects on transcription, one would expect this effect to diminish or disappear altogether upon chloramphenicol treatment. Our experimental data ([Figure 1](#F1){ref-type="fig"}D) show that transcriptional stimulation, caused by short (GAA)*~n~* repeats, disappears in the presence of chloramphenicol. At the same time, transcription inhibition caused by longer repeats becomes profound, resulting in a roughly 5-fold inhibition of the RNA synthesis by the 100-repeat stretch. No truncated products were observed (data not shown), indicating that either RNA synthesis at long (GAA)*~n~* repeats was arrested rather than terminated, or was in fact terminated but the truncated products rapidly degraded.

Two groups of data indicate that the elevated level of RNAs carrying short (GAA)*~n~* repeats is due to their increased stability. First, stabilities of repeat-containing and control RNAs were directly compared in conditions where transcription was arrested by rifampicin by measuring the levels of full-length messages as a function of time upon antibiotic addition. [Figure 2](#F2){ref-type="fig"}A shows the primary experimental data and [Figure 2](#F2){ref-type="fig"}B presents their quantitative analysis. One can clearly see that repeat-free RNA rapidly degrades, decaying by an order of magnitude within the first 7 min and as much as 50-fold after 17 min post transcription blockage. At the same time, RNA containing 18, 44, or 60 (GAA)*~n~* repeats are significantly more stable: there is only a 4- to 6-fold decay after 17 min in the presence of rifampicin. Interestingly, this stabilization does not differ significantly between 18 and 60 repeats, indicating that normal-size (GAA)*~n~* repeats are already sufficient to stabilize RNA in *E. coli* cells. Figure 2.Measuring RNA stability in rifampicin-treated cells. **(A)** Northern blot analysis of the control and GAA-containing RNAs at different time points upon rifampicin addition. **(B)** Quantitative analysis of the northern blot data. Squares---control RNA, diamonds---(GAA)~18~-containing RNA, circles---(GAA)~44~-containing RNA, triangles---(GAA)~60~-containing RNA.

Second, we compared control and repeat-containing transcripts in the RNase E mutant. RNase E is the key component of degradosome, which is the major player in the endonucleolytic degradation of bacterial RNA. [Figure 1](#F1){ref-type="fig"}E shows the results of transcription experiments performed in the N3431 strain carrying a temperature-sensitive *rne-3071* mutation. At the non-permissive temperature, short (GAA)*~n~* repeats lead to only a marginal increase in the amount of transcripts, indicating that amplification of the corresponding transcripts in the wild-type cells was due to the RNA stabilization. Long repeats, such as (GAA)~114~, cause a significant (3-fold) decrease in transcription relative to the control, apparently due to unmasking RNA stabilization in the RNase E mutant.

Altogether, our data indicate that short (GAA)*~n~* repeats stabilize RNA transcripts in *E. coli* whereas long repeats lead to fairly strong, albeit incomplete, transcription inhibition. Since this inhibition is particularly evident in chloramphenicol-treated cells, it is likely caused by the repeat structure rather than by protein binding to it.

Transcription through (GAA)*~n~*·(TTC)*~n~* repeats *in vitro*
--------------------------------------------------------------

If the interpretation of transcription data *in vivo* is correct, one would expect a strong inhibitory effect of (GAA)*~n~* runs on *E. coli* RNA polymerase *in vitro*. Note that the only data on the effects of (GAA)*~n~* repeats on the activity of purified transcription complexes were obtained for the T7 RNA polymerase ([@B11],[@B12]). Since *E. coli* RNA polymerase belongs to the same family as mammalian RNA polymerase II, analysis of its progression through (GAA)*~n~*·(TTC)*~n~* repeats seems more relevant to human disease than that of a phage polymerase.

For these studies, we used the promoter-independent initiation with the immobilized transcription system ([@B23]). Briefly, the elongation complexes assembled on a synthetic DNA template with a 9-nt RNA primer, labeled at its 5′ end, were ligated *in vitro* to the DNA fragments containing (GAA)*~n~*·(TTC)*~n~* or a control sequence of a comparable length. The RNA polymerase was then 'walked' to the first UTP in position +46 in the presence of ATP, GTP and CTP. The resulting elongation complex was stalled just a few bases upstream from the repeat. Addition of all four NTPs allowed transcription run-off with three possible outcomes: (i) productive transcription through the repeat; (ii) transcription arrest within the repeat without RNA polymerase dissociation; or (iii) premature transcription termination inside the repeat ([Figure 3](#F3){ref-type="fig"}). To access the transcription efficiency though the repeat, the amount of the 45-nt RNA (before chase) was compared with the amount of the run-off RNA from the complexes that successfully transcribed through the repeat. Figure 3.Schematic representation of the transcription experiment *in vitro*. Immobilized RNA polymerase binds to the RNA primer (arrow) annealed to a single-strand DNA oligonucleotide. A complementary non-template DNA is then added to the complex, creating a 3′ overhang for the repeat-containing fragment ligation. The repeat-containing fragment is excised from the plasmid and ligated to the elongation complex. After addition of ATP, CTP and GTP, the elongation complex is stalled upstream from the repeat. Three scenarios are possible after this stalled complex is released in the presence of all four NTPs: (i) successful transcription through the repeat; (ii) transcription arrest within the repeat; and (iii) transcription termination within the repeat.

[Figure 4](#F4){ref-type="fig"}A shows that the (GAA)~57~ repeat in the sense strand severely inhibited transcription under these experimental conditions. While roughly 40% of starting EC45s formed run-off products upon chase with all four NTPs on the control and (TTC)*~n~*-encoding templates ([Figure 4](#F4){ref-type="fig"}A (lanes 2 and 6) and B), only 7% of those complexes were able to complete transcription through the repetitive stretch on (GAA)*~n~*-encoding templates ([Figure 4](#F4){ref-type="fig"}A (lane 4) and B). Overexposure of the gel revealed an array of shorter RNAs spanning the entire repetitive run ([Figure 4](#F4){ref-type="fig"}A, lane 7). Therefore, the repeats caused either transcription arrest or termination. Figure 4.RNA polymerase progression is blocked by the (GAA)*~n~* repeats *in vitro*. **(A)** The immobilized elongation complexes were ligated to the linear fragment containing the repeat (GAA or TTC in the sense strand) or the control sequence. The 45-nt RNA in the starting EC and the 300-nt run-off (RO) product are indicated by arrows. **(B)** Quantitative analyses of data shown in (A); the fraction of the starting elongation complexes that reached the end of the template reflects the transcription efficiency. **(C)** The ECs obtained as in (A) were chased for 5 min with 1 mM NTPs, the KCl concentration was adjusted to 1 M, and the complexes were incubated in high salt for an additional 5 min. Then, the supernatant was removed (S, odd lanes) and loaded side-by-side with the unfractionated reaction mix (T, even lanes). The run-off products are indicated by arrows; the range of the transcripts from the TECs blocked by the repeat is shown by a red line.

It was possible to distinguish between the two alternatives because transcription was performed with the immobilized elongation complexes. In this system, transcription termination results in the release of the RNA in the supernatant. In [Figure 4](#F4){ref-type="fig"}C, the products released in the supernatant (lanes 1, 3 and 5) were analyzed side-by-side with the unfractionated reaction mixtures (lanes 2, 4 and 6). One can see that the transcripts shorter than the run-off product, which evidently belong to the elongation complexes stopped within the (GAA)*~n~* repeat (a smear indicated by a vertical bar in [Figure 4](#F4){ref-type="fig"}A, lane C), have not been released to the supernatant (lane 1) but remained associated with the polymerase (lane 2), thus suggesting that the (GAA)*~n~* repeat presents a block for the transcription elongation, but does not cause its premature termination. In contrast, the run-off product was completely released in supernatant, indicating that the disruption of the elongation complex results in dissociation of the transcript from the immobilized RNA polymerase.

Altogether, our *in vitro* data show RNA polymerase stalling by (GAA)*~n~* repeats in the sense strand for transcription and the lack of such stalling by (TTC)*~n~* repeats.

Effect of normal-size (TTC)*~n~* repeats on RNA stability *in vivo*
-------------------------------------------------------------------

Based on the above *in vitro* data, one should not expect transcription inhibition by (TTC)*~n~* repeats in the sense strand for transcription. Strikingly, however, we observed that transcription of plasmids carrying normal-size (TTC)*~n~* repeats in the sense strand resulted in the appearance of specifically truncated mRNAs ([Figure 5](#F5){ref-type="fig"}). The lengths of the shortened RNA species indicated that truncations occurred around (UUC)*~n~* repeats. Furthermore, the fraction of truncated products rapidly increased with an increase in the repeat\'s length whereas the fraction of the full-size transcripts concurrently decreased. This length dependence strongly suggested that (TTC)*~n~* repeats in the sense strand were indeed responsible for the RNA truncation. Hybridization of the same blots with the probe corresponding to the 3′ end of the *cat* mRNA ([Figure 5](#F5){ref-type="fig"}B) revealed only full-size RNA transcripts but not the 3′ truncations. This could either be due to the lack of transcription beyond short (TTC)*~n~* runs or an endonucleolytic cleavage of the repeat-containing transcripts followed by the rapid degradation of their 3′ halves. Figure 5.Effect of normal-size (TTC)*~n~* repeats on RNA synthesis in *E. coli* cells. Northern blot analysis of UUC-containing mRNAs from the wild-type *E. coli* cells. Hybridization was carried out with either the 5′ or 3′ part ([Figure 1](#F1){ref-type="fig"}A) of the repeat-containing transcript.

Since (GAA)*~n~*·(TTC)*~n~* repeats are capable of forming triplex DNA structures, we first analyzed whether transcript truncations in the (TTC)*~n~* orientation were due to the formation of intramolecular triplexes (H-DNA). To check this hypothesis, we used an approach based on the fact that intramolecular triplexes require the mirror symmetry from a homopurine--homopyrimidine repeat. We generated mutants M1 and M2 that carried two C-to-T transitions in either the 5′ or 3′ half of the (TTC)~15~ repeat, respectively, thus destroying its mirror symmetry without changing the CT content. We have also generated a mutant M12, which combined substitutions from the M1 and M2 mutants together, restoring the mirror symmetry of the repeat. Northern blot analysis of transcripts from the resultant plasmids revealed that RNA truncations at TC-rich stretches remained the same for all three mutants and was indistinguishable from that in the non-interrupted (TTC)~15~ stretch ([Figure 6](#F6){ref-type="fig"}). We therefore concluded that RNA truncations did not depend on the repeat\'s ability to form triplex structures. Since the RNA pattern did not change even in the M12 mutant where the (TTC)*~n~* repeat was significantly disturbed, we concluded that the perfect repetitive nature of the sequence is not required for transcript truncations. Figure 6.RNA truncations caused by (TTC)*~n~* repeats are not due to the H-DNA formation. RNA from a plasmid with the (TTC)~15~ repeat and three mutant derivatives of this repeat, M1, M2 and M12, was analyzed by northern blot hybridization with the 5′ probe shown in [Figure 1](#F1){ref-type="fig"}A.

Since we did not observe transcription inhibition *in vitro* for the (TTC)*~n~*-encoding template but saw a potent truncation of the UUC-containing transcripts *in vivo*, we strongly suspected that these truncations could be due to RNA cleavage at or within (UUC)*~n~* repeats. To study whether (UUC)*~n~* repeats within mRNAs could lead to their degradation, we have chosen a genetic approach based on the use of various RNase mutants in *E. coli*. Specifically, we analyzed (UUC)*~n~*-containing mRNA synthesis in strains that carried mutations in the genes encoding RNase I, RNase III, RNase H, RNase P and RNase E. Mutant and isogenic control strains were transformed with the plasmids carrying (TTC)~20~ repeats in the sense strand for transcription, and RNA products were analyzed by northern blot hybridization. Mutations in RNase I, RNase III, RNase H and RNase P did not have any effect on the synthesis of repeat-containing mRNA and/or accumulation of truncated RNA fragments (data not shown).

RNase E, to the contrary, appeared to be crucial for the repeat-caused RNA cleavage. Since RNase E is an essential protein, we used a temperature-sensitive *rne-3071*(*ts*) mutant and followed the fate of (UUC)*~n~*-containing RNAs upon shifting the logarithmic cells to different temperatures. [Figure 7](#F7){ref-type="fig"} shows a clear-cut decrease in the amount of truncated RNA fragments at the non-permissive compared to permissive temperatures. RNase E is the key component of the so-called degradosome, which is involved in the endonucleolytic degradation of bacterial mRNA. We believe, therefore, that RNA cleavage within (UUC)*~n~* repeats by the bacterial degradosome is responsible for the accumulation of truncated RNAs, which could be mistaken for the products of premature transcription attenuation. Figure 7.RNase E is responsible for the cleavage of (UUC)*~n~*-containing RNAs. Northern blot analysis of repeat-containing RNA isolated from the JM109 (control) and N3431 (*rne*^ts^) cells carrying the p185ΔCTT20 plasmid. Prior to RNA isolation, cells were incubated at permissive (30°C), semi-permissive (37°C) or non-permissive (43°C) temperatures for 1 h.

DISCUSSION
==========

The reduced amount of transcripts carrying expanded (GAA)*~n~* repeats in the sense strand for transcription was detected in FRDA patients ([@B8],[@B9]) and in transient transfection experiments with cultured mammalian cells ([@B10]). At the same time, expanded (GAA)*~n~* runs did not strongly affect transcription in yeast plasmids ([@B19]) or in the FRDA knock-in mice ([@B27]). The reasons for these discrepancies are unclear. Furthermore, while it is generally believed that expanded repeats block transcription elongation ([@B9],[@B10]), other mechanisms such as changes in the chromatin structure ([@B17]) or RNA splicing can be considered.

To gain a better insight into the mechanisms of gene repression caused by FRDA repeats, we analyzed the effects of (GAA)*~n~*·(TTC)*~n~* repeats of varying lengths and orientations within an *E. coli* plasmid on transcription. The advantage of this system is that in the lack of chromatin structure and RNA splicing, the results are easier to interpret in terms of transcription and RNA stability.

Rather unexpectedly, we have found that progressive lengthening of (GAA)*~n~* runs in the sense strand for transcription first leads to an increase followed by a decrease in the amount of the repeat-containing transcript ([Figure 1](#F1){ref-type="fig"}C). The initial increase was completely eliminated upon chloramphenicol treatment of *E. coli* cells ([Figure 1](#F1){ref-type="fig"}D), indicating that it was protein mediated. Furthermore, a much more modest increase was observed in the RNase E mutant ([Figure 1](#F1){ref-type="fig"}E). These data suggested that short (18 \< *n* \< 50) (GAA)*~n~* repeats stabilize RNA transcripts in *E. coli* cells. We have proven this suggestion by measuring stabilities of control and repeat-containing RNA in cells treated with the transcription inhibitor rifampicin ([Figure 2](#F2){ref-type="fig"}). While the reasons of this stabilization remain to be unraveled, an increase in the mRNA levels at carrier-size repeat lengths was also reported for other expansion diseases ([@B28; @B29; @B30]).

Expanded (*n* \> 50) (GAA)*~n~* repeats in the sense strand for transcription significantly decreased transcription efficiency. This effect was particularly pronounced in cells treated with chloramphenicol or in the RNase E mutant ([Figure 1](#F1){ref-type="fig"}D and E). Furthermore, the strength of transcription inhibition increased proportionally to the repeat\'s length. These results are highly indicative that the repeat\'s secondary structure, rather than protein binding to it, is responsible for the transcription inhibition.

This assumption is further supported by our *in vitro* studies of the *E. coli* RNA polymerase. Transcription was notably delayed within (GAA)*~n~* runs in linear templates. At the same time, premature termination within a repetitive run did not occur *in vitro* or *in vivo*, suggesting that the polymerase\'s progression was arrested within the repeat but not aborted altogether. Note that transcription inhibition *in vitro* was significantly stronger than that observed *in vivo*: the same (GAA)~57~ repeat inhibits transcription 6-fold *in vitro* but only 2-fold in chloramphenicol-treated cells. While the reasons for this discrepancy are unknown, we believe that accessory transcription factors facilitate the RNA polymerase progression through repetitive DNA.

By-and-large, our data on the effects of (GAA)*~n~* runs on transcription are in line with the previous hypotheses implicating unusual secondary structures of FRDA repeats in transcription attenuation ([@B9; @B10; @B11; @B12],[@B31]). The exact structure responsible for this transcription slowing remains to be elucidated. (GAA)*~n~*·(TTC)*~n~* runs belong to the class of homopurine--homopyrimidine mirror repeats that are capable of forming intramolecular DNA triplexes, such as H-DNA ([@B32]) or 'sticky' DNA ([@B33],[@B34]). Formation of intramolecular triplexes requires a local unwinding of the DNA, which appears naturally during the course of transcription. If the non-template single-stranded DNA in the transcription bubble contains (GAA)*~n~* repeats, it can fold back to form the triplex-like structure, trapping elongating RNA polymerase ([@B11]). Another structure that could contribute to transcription stalling is a quasi hairpin built of (GAA)*~n~* repeats ([@B35]). It can form a roadblock in DNA in front of the elongating RNA polymerase or attenuate the RNA polymerase progression by forming in the newly synthesized RNA. The structural model is also consistent with our observations that chloramphenicol treatment amplifies repeat-caused transcription attenuation *in vivo*. Chloramphenicol treatment is known to increase plasmid DNA supercoiling in *E. coli* ([@B36]) that in turn facilitates formation of DNA triplexes ([@B37]).

A totally unexpected phenomenon observed in the course of our studies is that positioning normal-size (TTC)*~n~* runs into the sense strand for transcription results in the degradation of (UUC)*~n~*-containing mRNAs in *E. coli*. This degradation was significantly reduced in the conditionally lethal RNase E mutant at the non-permissive temperature ([Figure 6](#F6){ref-type="fig"}). RNase E is an integral component of the bacterial degradosome, which is crucial for the initial stages of the decay of the majority of mRNAs in *E. coli* ([@B38]). We therefore conclude that (UUC)*~n~* stretches serve as targets for the bacterial degradosome. The sequence specificity of RNase E is still unclear. Early efforts to determine the substrate specificity resulted in the following consensus sequence: RAUUU/A ([@B39]). Subsequent analysis revealed that RNase E prefers single-stranded AU-rich RNA regions ([@B40]). This study points to another motif, (UUC)*~n~*: 10 repeats were enough to trigger mRNA decay, and it became highly significant at 20 repeats. These data point to a potential mechanism for gene repression by expandable repeats via accelerated RNA degradation.

Is this observation relevant for eukaryotic systems? To address this question, we analyzed the effect of (TTC)*~n~* repeats on RNA degradation in yeast cells. For this purpose, (GAA)*~n~*·(TTC)*~n~* repeats of different lengths or a control 188-bp non-repetitive sequence were cloned downstream of the GAL1 promoter such that (TTC)*~n~* runs appeared in the sense strand for transcription ([Figure 8](#F8){ref-type="fig"}A). Upon transcription induction by the galactose, total RNA was isolated and analyzed by northern hybridization. Hybridization with the probe, corresponding to the 5′ part of the transcript, revealed the accumulation of short transcription products evidently truncated at the position of the (UUC)*~n~* repeat ([Figure 8](#F8){ref-type="fig"}B). The accumulation of these truncations was clearly dependent on the repeat\'s length; they were non-existent at 20 repeats, evident at 35 repeats and became the main RNA species at 60 repeats. Hybridization with the 3′ probe revealed traces of RNAs, whose lengths corresponded to the distance from the (UUC)*~n~* run to the transcription terminator. We therefore believe that RNA truncations are likely caused by the UUC-mediated RNA degradation in yeast, similar to what was observed in bacteria. Since there is no known homolog of RNase E in yeast, it would be of prime interest to identify yeast RNase(s) responsible for this degradation. While UUC-mediated RNA degradation has not yet been observed in cultured mammalian cells ([@B10]), our data warrant revisiting this issue. It would also be interesting to study whether other pyrimidine-rich expandable repeats cause RNA degradation *in vivo*. Figure 8.Effects of (TTC)*~n~* repeats on RNA expression in yeast *S. cerevisiae*. **(A)** The scheme of linearized yeast reporter plasmid showing a yeast transcription cassette (shown in light grey) consisting of GAL1 promoter, 210-bp 5′ part, (TTC)*~n~* repeat, and 572-bp 3′ part. 5′ and 3′ probes for northern hybridization are shown. **(B)** Northern hybridization analysis of the repeat-containing and control RNA transcripts.
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